Key Market Indicators
**Lithuanian Insulin Imports Projected to Climb to $24 Million by 2028** Lithuanian insulin imports are expected to reach approximately $24 million by 2028, up from about $22 million in 2023. This marks an average annual growth rate of 1.3%. Since 1999, the demand for insulin in Lithuania has increased by an average of 3.3% per year. **Insulin Exports from Lithuania to Hit $14 Million by 2028** On the export front, Lithuania's insulin exports are forecasted to grow to nearly $14 million by 2028, rising from about $12 million in 2023. This represents an average annual growth rate of 2.3%. Since 1999, the country's insulin supply has surged by an average of 4.5% per year. In 2023, Lithuania ranked 17th in the world for insulin exports, with Poland overtaking it at approximately $12 million. The top three countries in this ranking were France, Italy, and China, respectively.
